Rethinking antimicrobial prophylaxis in patients receiving medicinal leech therapy

James Andrew McCracken, Steven M. Koehler, Roopali Sharma

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

Purpose: To describe challenges in the management of prophylaxis against infections for patients receiving medicinal leech therapy given changes in antimicrobial resistance patterns in the normal flora of leeches. Summary: This article presents a patient case of reconstructive surgery complicated by infection associated with the use of medicinal leeches, as well as a discussion of prophylaxis in medicinal leech therapy, focusing on considerations for choosing a prophylactic agent. Conclusion: Our case report highlights resistance changes in Aeromonas isolates associated with medicinal leeches and the potential for complications if isolates resistant to chosen prophylactic agents arise. When administering antimicrobial prophylaxis in patients receiving medicinal leech therapy, clinicians should be familiar with the susceptibilities of Aeromonas species but also conscious of evolving antimicrobial resistance given the extent of the consequences of infected surgical grafts.

Original languageEnglish (US)
Pages (from-to)E14-E19
JournalAmerican Journal of Health-System Pharmacy
Volume79
Issue number1
DOIs
StatePublished - Jan 1 2022
Externally publishedYes

Keywords

  • Aeromonas
  • Hirudo medicinalis
  • antimicrobial resistance
  • antimicrobial stewardship
  • leeching
  • medicinal leech therapy

ASJC Scopus subject areas

  • Pharmacy
  • Pharmacology
  • Health Policy

Fingerprint

Dive into the research topics of 'Rethinking antimicrobial prophylaxis in patients receiving medicinal leech therapy'. Together they form a unique fingerprint.

Cite this